NCT05089604View on ClinicalTrials.gov

Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations

PHASE4RecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

December 31, 2026

Conditions
Liver TransplantationImmunosuppressionNeurotoxicityTremorTacrolimus
Interventions
DRUG

Tacrolimus, Immediate Release, Oral

Twice Daily Tacrolimus

DRUG

Tacrolimus Extended Release Oral Tablet

Once Daily Tacrolimus

Trial Locations (1)

V5Z 1M9

RECRUITING

Vancouver General Hospital, Vancouver

Sponsors

Collaborators (1)

Paladin Labs Inc.
All Listed Sponsors
collaborator

Paladin Labs Inc.

OTHER

lead

University of British Columbia

OTHER

NCT05089604 - Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations | Biotech Hunter | Biotech Hunter